Effect of pharmaceutical formulation of diltiazem on the utilization of medicaid and health maintenance organization services
- 31 October 1994
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 55 (10) , 1136-1149
- https://doi.org/10.1016/s0011-393x(05)80254-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal LevelsJAMA, 1992
- Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic HypertensionJAMA, 1991
- An updated coronary risk profile. A statement for health professionals.Circulation, 1991
- National High Blood Pressure Education Program Working Group Report on Ambulatory Blood Pressure MonitoringArchives of internal medicine (1960), 1990
- Drug Formularies: Myths-ln-FormationMedical Care, 1990
- Effects of Communitywide Education on Cardiovascular Disease Risk FactorsJAMA, 1990
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Medicaid Drug Formulary RestrictionsThe Journal of Law and Economics, 1989
- Medicaid Patients' Access To New DrugsHealth Affairs, 1988
- The social drug lag: An examination of pharmaceutical approval delays in medicaid formulariesSocial Science & Medicine, 1985